This is an observational, monocentric study, consisting of both a retrospective and a prospective component. The aim of the study is to identify risk and protective factors for alcohol relapse in patients with alcohol-related liver disease (ARLD) who have undergone orthotopic liver transplantation (OLT).
For the retrospective part of the study, clinical data will be collected and analyzed from patients diagnosed with ARLD and with components of exotoxicity who underwent liver transplantation in the past five years. This data will be obtained from patient medical records, including results from laboratory tests and multidisciplinary outpatient consultations conducted as part of routine clinical practice. The prospective phase of the study will involve the consecutive enrollment of patients diagnosed with ARLD or with exotoxicity-related etiological components who are undergoing liver transplantation at the IRCCS AOUBO. Four patient assessment points are planned, which will take place during routine follow-up visits already scheduled as part of the patient's care pathway. During these visits, data will be collected on the patient's medical history, laboratory and/or histological results, as well as diagnostic and surgical information. Additionally, through the administration of clinical questionnaires, data will be gathered on the patient's psychiatric-psychological status, history of exotoxicity, and psychosocial background.
Study Type
OBSERVATIONAL
Enrollment
320
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy
RECRUITINGalcohol relapse rate
To describe the population undergoing liver transplantation with a diagnosis of ARLD and exotoxicity-related components in terms of alcohol relapse rate
Time frame: 7 years
alcohol recurrence rate
To describe the population undergoing liver transplantation with a diagnosis of ARLD and exotoxicity-related components in terms of alcohol recurrence rate
Time frame: 7 years
Clinical data to assess the risk of alcohol relapse
Collection of clinical data on liver disease through routine visits to assess the risk of alcohol relapse at 12 months post-OLT
Time frame: 7 years
psychiatric evaluation to assess the risk of alcohol relapse
Administration of a clinimetric assessment composed of psychometric, self-assessment tests, already validated and widely used in the literature
Time frame: 7 years
Impact of alcohol relapse/recurrence on liver transplant outcomes
To assess the impact of alcohol relapse/recurrence on liver transplant outcomes.
Time frame: 7 years
Identifying Risk and Protective Factors for Alcohol Relapse
To identify potential risk and protective factors for alcohol relapse and, consequently, to develop a multiparametric/multimodal operational model for evaluating candidates for liver transplantation
Time frame: 7 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.